Aztreonam-avibactam activity against Enterobacterales from United States medical centers: Summary of 5 years of surveillance prior to approval for clinical use (2020–2024)

Aztreonam-avibactam activity against Enterobacterales from United States medical centers: Summary of 5 years of surveillance prior to approval for clinical use (2020–2024). Lead author: Helio S. Sader, presented at IDWeek 2026, Oct 22, Washington D.C., USA
Poster P-117